Evidence map›Paper›PMID 27485323›Full record

ArticleArthritis research & therapy2016

MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.

Debbie M Boeters, Wouter P Nieuwenhuis, Marije K Verheul, Elize C Newsum, Monique Reijnierse, René E M Toes, Leendert A Trouw, Annette H M van der Helm-van Mil

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Debbie M BoetersDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands. D.M.Boeters@lumc.nl.
Wouter P NieuwenhuisDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands.
Marije K VerheulDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands.
Elize C NewsumDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands.
Monique ReijnierseDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
René E M ToesDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands.
Leendert A TrouwDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands.
Annette H M van der Helm-van MilDepartment of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden, 2300, RC, The Netherlands.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn rheumatoid arthritis (RA) bone marrow edema (BME, osteitis) and anti-citrullinated protein antibodies (ACPA) are associated with radiographic progression. ACPA have been associated with BME, but it is unknown if this association is confined to ACPA and BME. We performed cross-sectional analysis of the association of ACPA, rheumatoid factor (RF) and anti-carbamylated protein (anti-CarP) antibodies with BME and other types of inflammation (synovitis, tenosynovitis) detected by magnetic resonance imaging (MRI).

methodsDisease-modifying antirheumatic drug (DMARD)-naïve patients with early arthritis (n = 589), included in the Leiden Early Arthritis Clinic cohort, underwent contrast-enhanced 1.5 T MRI of unilateral wrist, metacarpophalangeal and metatarsophalangeal-joints at baseline. BME, synovitis and tenosynovitis were scored by two readers. ACPA, rheumatoid factor (RF) and anti-CarP were determined at baseline.

resultsIn univariable analyses ACPA-positive patients had higher BME scores than ACPA-negative patients (median 4.5 vs. 2.0, p < 0.001), but not more synovitis and tenosynovitis. Also RF (median 3.75 vs. 2.0, p < 0.001) and anti-CarP antibodies (median 3.5 vs. 2.5, p = 0.012) were associated with higher BME scores. Because the autoantibodies were concomitantly present, analyses were stratified for the presence of different autoantibody combinations. ACPA-positive (ACPA+), RF-negative (RF-), anti-CarP-negative (anti-CarP-) patients did not have higher BME-scores than ACPA-negative (ACPA-), RF-, anti-CarP- patients. However ACPA+, RF-positive (RF+), anti-CarP- patients and ACPA+, RF+, anti-CarP-positive (anti-CarP+) patients had higher BME scores than ACPA-, RF-, anti-CarP- patients (median 5.0 and 4.5 vs. 2.0, p < 0.001 and p < 0.001). ACPA levels were not associated with BME scores. Analyses within RA- and UA-patients revealed similar results.

conclusionsThe presence of ACPA alone or ACPA level was not statistically significantly associated with BME scores, but the combined presence of ACPA and RF was associated with more BME. This suggests an additive role of RF to ACPA in mediating osteitis.

Indexed as

AdultAgedArthritis, RheumatoidAutoantibodiesAutoantigensCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedOsteitisPeptides, CyclicRheumatoid FactorAutoantibodiesAutoantigenscyclic citrullinated peptidePeptides, CyclicRheumatoid FactorACPABone marrow edemaMRIRFRheumatoid arthritis

Identifiers

PMID27485323
PMCPMC4971651
OpenAlexW2485182736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.